Methods and Systems for Measuring Serotonin in a Sample
AssigneeLaboratory Corporation of America Holdings
InventorsMatthew Lee Francis Crawford, Yvonne Zamorano Wright, Russell Philip Grant
Life of this patent
Estimating the term…
Abstract
Disclosed are methods and systems for measuring serotonin in a sample using liquid chromatography and mass spectrometry.
Claims34
A method for determining the presence or amount of released serotonin in a sample, the method comprising:
- providing a sample comprising a biological sample, donor platelets, and heparin;
- incubating the sample for a period of time to release serotonin from the donor platelets;
- chromatographically separating serotonin from other components in the incubated sample using liquid chromatography;
- and
- analyzing the chromatographically separated serotonin by mass spectrometry to determine the presence or amount of released serotonin in the sample.
A method for determining the presence or amount of released serotonin in a sample, the method comprising:
- providing a sample comprising a biological sample, heparin, and serotonin-incubated platelets;
- incubating the sample for a period of time to release serotonin from the platelets;
- chromatographically separating serotonin from other components in the incubated sample using liquid chromatography;
- and
- analyzing the chromatographically separated serotonin by mass spectrometry to determine the presence or amount of released serotonin in the sample relative to the total amount of serotonin available within the donor platelets.
A method for determining the presence or amount of released stable isotopically labeled serotonin in a sample, the method comprising:
- providing a sample comprising a biological sample, heparin, and stable isotopically labeled serotonin-incubated platelets;
- incubating the sample for a period of time to release stable isotopically labeled serotonin from the platelets;
- chromatographically separating stable isotopically labeled serotonin from other components in the incubated sample using liquid chromatography;
- and
- analyzing the chromatographically separated stable isotopically labeled serotonin by mass spectrometry to determine the presence or amount of released stable isotopically labeled serotonin in the sample relative to the total amount of isotopically labeled serotonin available within the donor platelets.
A method of generating a report useful for diagnosing a disease or condition associated with abnormal platelet activation, the method comprising:
- (a) providing a sample comprising a biological sample, donor platelets, and heparin;
- (b) incubating the sample for a period of time to release serotonin from the donor platelets;
- (c) chromatographically separating serotonin from other components in the incubated sample using liquid chromatography;
- (d) analyzing the chromatographically separated serotonin by mass spectrometry to determine the amount of released serotonin in the sample relative to the total amount of serotonin available within the donor platelets;
- and
- (e) generating a report that recites the percentage release of serotonin in the sample.
A system for determining the presence or amount of serotonin in a sample, the system comprising:
- (a) a station for providing a sample comprising a biological sample, donor platelets, and heparin;
- (b) a station for incubating the sample for a period of time to release serotonin from the donor platelets;
- (c) a station for chromatographically separating serotonin from other components in the incubated sample using liquid chromatography;
- and
- (d) a station for analyzing the chromatographically separated serotonin by mass spectrometry to determine the presence or amount of released serotonin in the sample relative to the total amount of serotonin available within the donor platelets.
Dependencies are inferred from the claim text.